145 related articles for article (PubMed ID: 32682887)
1. Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
Williams EA; Shah N; Danziger N; Montesion M; Sokol ES; Pavlick DC; Miller VA; Ross JS; Elvin JA; Tse JY
J Am Acad Dermatol; 2021 Apr; 84(4):1069-1071. PubMed ID: 32682887
[No Abstract] [Full Text] [Related]
2. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
3. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
[TBL] [Abstract][Full Text] [Related]
4. C-kit expression of melanocytic neoplasm and association with clinicopathological parameters and anatomic locations in Chinese people.
Lin YC; Chang YM; Ho JY; Lin HC; Tsai YM; Chiang CP; Wang WM; Gao HW
Am J Dermatopathol; 2013 Jul; 35(5):569-75. PubMed ID: 23221472
[TBL] [Abstract][Full Text] [Related]
5. Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.
Cesinaro AM; Natoli C; Grassadonia A; Tinari N; Iacobelli S; Trentini GP
J Invest Dermatol; 2002 Jul; 119(1):187-90. PubMed ID: 12164944
[No Abstract] [Full Text] [Related]
6. [Cutaneous melanocytic tumors. Case 2].
Castillo C
Ann Pathol; 2016 Oct; 36(5):322-325. PubMed ID: 27639774
[No Abstract] [Full Text] [Related]
7. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
8. Melanocytic lesions: current state of knowledge.
Zembowicz A; Prieto VG
Arch Pathol Lab Med; 2010 Dec; 134(12):1738-9. PubMed ID: 21128769
[No Abstract] [Full Text] [Related]
9. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors.
Filimon A; Zurac SA; Milac AL; Sima LE; Petrescu SM; Negroiu G
Melanoma Res; 2014 Jun; 24(3):219-36. PubMed ID: 24709887
[TBL] [Abstract][Full Text] [Related]
10. BRAFV600E mutation in oral melanocytic nevus and oral mucosal melanoma.
Resende TAC; de Andrade BAB; Bernardes VF; Coura BP; Delgado-Azãnero W; Mosqueda-Taylor A; de Almeida OP; Gomes CC; Gomez RS
Oral Oncol; 2021 Mar; 114():105053. PubMed ID: 33189579
[No Abstract] [Full Text] [Related]
11. The role of oncogenes and growth factors in progressive melanoma-genesis.
Albino AP
Pigment Cell Res; 1992; Suppl 2():199-218. PubMed ID: 1409423
[No Abstract] [Full Text] [Related]
12. [Dysplastic nevus syndrome, familial predisposition toward getting melanomas].
van den Berg WH; Neering H
Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1969-71. PubMed ID: 7312070
[No Abstract] [Full Text] [Related]
13. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular genetics of Carney complex.
Rothenbuhler A; Stratakis CA
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):389-99. PubMed ID: 20833331
[TBL] [Abstract][Full Text] [Related]
15. Melanocytic nevi and melanoma: unraveling a complex relationship.
Damsky WE; Bosenberg M
Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
[TBL] [Abstract][Full Text] [Related]
16. Melanoma arising in a nevus of Ito: novel genetic mutations and a review of the literature on cutaneous malignant transformation of dermal melanocytosis.
Tse JY; Walls BE; Pomerantz H; Yoon CH; Buchbinder EI; Werchniak AE; Dong F; Lian CG; Granter SR
J Cutan Pathol; 2016 Jan; 43(1):57-63. PubMed ID: 26260725
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous melanoma arising in agminated melanocytic nevi: CDKN2A and CDK4 mutation screening.
Rezze GG; Leon A; Silva DC; Neves RI; Molina GC; Carraro DM; Landman G; Duprat JP
Acta Derm Venereol; 2012 Jan; 92(1):98-9. PubMed ID: 21710107
[No Abstract] [Full Text] [Related]
18. Epithelioid and fusiform blue nevus of chronically sun-damaged skin, an entity distinct from the epithelioid blue nevus of the Carney complex.
Yazdan P; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2013 Jan; 37(1):81-8. PubMed ID: 22892599
[TBL] [Abstract][Full Text] [Related]
19. DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines.
Rass K; Gutwein P; Welter C; Meineke V; Tilgen W; Reichrath J
Histochem J; 2001 Aug; 33(8):459-67. PubMed ID: 11931386
[TBL] [Abstract][Full Text] [Related]
20. Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes.
Cohen JN; Joseph NM; North JP; Onodera C; Zembowicz A; LeBoit PE
Am J Surg Pathol; 2017 Oct; 41(10):1333-1346. PubMed ID: 28796000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
